Is elevated citramalic acid a marker of bacterial dysbiosis?

Urinary organic acid testing often reveals elevated levels of citramalic acid. While some organic acids reflect endogenous mitochondrial health, citramalic acid serves as an indicator of gastrointestinal microflora status rather than a direct biomarker of normal human metabolic pathways.

Clinical and microbial significance

• Indicator of dysbiosis: Elevated citramalic acid is strongly associated with bacterial dysbiosis, altered microbial fermentation, and yeast overgrowth. It is primarily synthesized by gastrointestinal microorganisms, including Saccharomyces species, Propionibacterium, and molds like Aspergillus niger.
• Systemic excretion: Following microbial synthesis in the gut, citramalic acid is absorbed across the intestinal epithelium, enters systemic circulation, and is excreted in urine, making it a reliable clinical marker for altered gastrointestinal ecology.

Mechanistic pathways and mitochondrial impact

• TCA cycle exclusion: Citramalic acid is not a canonical intermediate of the human citric acid (TCA) cycle, and endogenous host synthesis is negligible.
• Competitive inhibition: Mechanistically, citramalic acid acts as a structural analog of L-malate. Elevated levels competitively inhibit L-malate metabolism in human mitochondria, potentially impairing host energy production rather than supporting it.

Bottom line

• Elevated urinary citramalic acid indicates bacterial dysbiosis or fungal overgrowth rather than human host metabolism, and its accumulation can actively impair mitochondrial energy production by competitively inhibiting L-malate.